individual investors
institutions & advisors
My Value Line
Sign In
Subscribe
Value Line
smaller
default
larger
Research Hub
Stocks
Overview
Dow 30 Coverage
Investment Survey
Investment Survey Plus
Small & Midcap Survey
Special Situations
Select
Dividend Select
Value Line 600
Analyzer
Funds
Overview
Fund Advisor
Fund Advisor Plus
Fund Survey for Windows
Options
Overview
Options Survey
Convertibles
Overview
Convertibles Survey
ETF
ETF Professional
Tools
Overview
Screener
Model Portfolio
Portfolio Tracker
Glossary
Markets
Overview
Daily Updates
Economic Calendar
Commentary
Products
Overview
Stocks
Funds
Options
Convertibles
ETFs
Data Licensing
Research Center
Investment Education
Overview
Getting Started
How To Use
Sample Reports
Guides
Articles
FAQs
Glossary
Free Reports
Ranks
Research
My Value Line
Market Review
Symbol Lookup
Products
Research Center
Investment Survey
Investment Survey Plus
Value Line 600
Small & Midcap Survey
Select
Dividend Select
Special Situations
Analyzer
Fund Advisor
Fund Advisor Plus
Fund Survey for Windows
Options Survey
Convertibles Survey
ETF Professional
Free Reports
Need help?
View Our FAQs
Retrieve Password
Contact Us
View Our Guides
Glossary
Quote Lookup
Please enter a ticker symbol below and click Submit.
Symbol:
VL Survey Page
(2013-04-12)
Quotes
News
Option Data
Graphs
Time/Sales
Novartis Ag (NVS)
2013-05-22@15:30:11 ET
Shares of Novartis Rise to a New 52-Week High (F71)
2013-05-22@13:30:12 ET
Australia Patent: Application for 'Quinazolinone derivatives useful as vanilloid antagonists' Lapses (ABW)
2013-05-22@10:06:43 ET
Disruptive Innovation Hits Clinical Trials, Dedicated Event Launches (PRW)
2013-05-22@08:00:00 ET
Dr. Heiri Gugger named Managing Director of new North Carolina office (PRN)
2013-05-22@07:48:21 ET
Isothermal Nucleic Acid Amplification Technologies Market 2012-2017: Global market forecasts including demand side analysis and strategic recommendations for technology/product developers (MTO)
2013-05-22@07:10:27 ET
Positive Data on Novartis' Afinitor (ZAX)
2013-05-22@03:29:01 ET
Australia Patent for 'Novel 1-aza bicycloalkyl derivatives for the treatment of psychotic and neurodegenerative disorders' Ceases (ABW)
2013-05-22@03:24:39 ET
Australia Patent for 'Combination of DPP-IV inhibitor, PPAR antidiabetic and metformin' Ceases (ABW)
2013-05-21@09:31:45 ET
Australia Patent: Application for 'Pyrazine derivatives as epithelial sodium channel blockers' Lapses (ABW)
2013-05-21@09:30:00 ET
Thought-Leader Opinion and Clinical Data Indicate that Emerging Agents from Two Drug Classes Have Efficacy Advantages Over Currently Used Therapies for HR-Positive, HER2-Negative Breast Cancer (PRN)
2013-05-21@08:16:09 ET
New data reinforces strength of Novartis once-daily COPD portfolio in improving lung function, shortness of breath and reducing rate of exacerbations (HUG)
2013-05-21@07:25:00 ET
Australia Patent: Application for '2 -arylaminoquinazolines for treating proliferative diseases' Lapses (ABW)
2013-05-21@03:35:10 ET
Australia Patent: Application for 'Pyrazolo [5,1-b] oxazole derivatives as CRF1 antagonists' Lapses (ABW)
2013-05-21@01:16:05 ET
Largest-ever global survey of 1,273 women in 12 countries reveals women with advanced breast cancer feel left out of the breast cancer movement (HUG)
2013-05-20@12:33:05 ET
BioPharmaceutical Industry in China - 2013 Analysis Available Now (MTO)
2013-05-20@10:56:00 ET
For Chronic Obstructive Pulmonary Disease, Surveyed Pulmonologists Indicate That Improved Effect on Quality of Life is One of the Greatest Unmet Needs (PRN)
2013-05-20@09:52:27 ET
Sandoz launches allergy rhinitis drug in Slovenia (DTM)
2013-05-20@07:48:41 ET
Global Vaccine Market Forecast to 2017 (MTO)
2013-05-20@07:48:31 ET
Genetic Testing Market Outlook to 2017 (MTO)
2013-05-20@07:30:00 ET
eFFECTOR Therapeutics Raises $45 Million in Series A Financing (PRN)